Addition of benzamide (BZ) at the onset of S phase inhibited expression of the neoplastic phenotype in human foreskin fibroblasts treated in vitro with (±)-7a,8(3-dihydroxy-9f3,10g3-epoxy-7,8,9,10-tetrahydrobenzo[a] [methyl-3H]thymidine (specific activity, 80 Ci/mmol) were purchased from New England Nuclear. Micrococcal nuclease, pancreatic RNase, proteinase K, and Sarkosyl were purchased from Sigma.
The covalent interaction of a carcinogen with the target cell DNA is considered as one of the major events in neoplastic transformation (1) (2) (3) . Proliferating cells in vivo and in vitro are found to be more sensitive to transformation by chemical carcinogens than nondividing cells (4, 5) , and this sensitivity is increased when the cells are treated in early S phase (6, 7) , presumably due to the higher binding of the carcinogen to the newly synthesized DNA (8) . A good correlation between carcinogenicity and DNA binding has been observed for a series of chemicals (2) .
Benzo [a] pyrene, a potent environmental carcinogen, requires metabolic activation by the microsomal enzymes to the ultimate carcinogen metabolites (9, 10) . The bay region epoxide (±)-7a,8f3-dihydroxy-9f3,103-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (B[a]P diol epoxide) has been identified as the ultimate metabolite that binds to the DNA. One of the major adducts formed results by the trans addition at the 10-position of B[a]P diol epoxide to the exocyclic amino group of guanine (11) . A correlation between the biological activity of B[a]P diol epoxide and the presence of B[a]P diol epoxide-guanine adducts in the modified DNA has been identified (12) . Furthermore, recent studies on the B[a]P diol epoxide-DNA adducts in the chromatin have revealed a nonrandom distribution, the linker DNA being modified to a greater extent than the nucleosome core DNA (13, 14) . It seems likely that B[a]P diol epoxide is capable of forming site-specific adducts under favorable conditions and this might have a profound effect on gene expression.
Previous studies from this laboratory have shown that the in vitro treatment of human foreskin fibroblasts, in early S phase, with B[a]P diol epoxide induced a neoplastic transformation in the low-passage responsive cell populations but not in the high-passage refractory cell populations. Moreover, we observed no significant difference in the level of DNA modification or in the specific carcinogen-DNA adduct profiles of both of these treated cell types (15) . Recently, benzamide (BZ), a specific inhibitor of poly(ADP-ribose) polymerase (16) , has been shown to inhibit the transformation of the responsive treated cells initiated by B[a]P diol epoxide (17) . Preliminary results, upon examination of specific carcinogen-DNA adduct formation, indicated that BZ did not alter the DNA modification. The data presented here expand on the preliminary report (18) (19) . These cells were maintained in 75-cm2 flasks in complete growth medium (CM), consisting of Eagle's minimal essential medium (MEM): 25 mM Hepes buffer (pH 7.2) supplemented with 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 2 mM glutamine, 50 ,g of gentamicin per ml, 0.2% sodium bicarbonate, and 10% fetal bovine serum. Cells at PDL-5 (population doubling-5) were blocked in the G1 phase by using a nutrient-deficient medium, released from the block, and treated in early S phase with [G-3H]B[a]P diol epoxide (15) . The final concentration of [G-3H]B[a]P diol epoxide used in these experiments was 0.34 ,g/ml of the treatment medium. After 3 hr of treatment, either the cells were harvested by mild trypsinization and pelleted by centrifugation at 1000 x g or the experimental medium was removed and the cultures were refed with CM and harvested 8 hr later.
In experiments in which the cells were treated with [G-3H]B[a]P diol epoxide in the presence of BZ, 1 mM BZ was added to the release medium at the onset of S phase of the cell cycle, 2 hr prior to the carcinogen treatment, and was maintained at this concentration throughout carcinogen treatment. 
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ide on the cells were determined in separate experiments by a colony-formation toxicity assay (20) . The effect of 1 mM BZ on the S phase of the cell cycle during the treatment period was measured by the incorporation of thymidine into the nuclear DNA by autoradiography (20) Isolation of Nuclei. All isolation procedures were carried out between 0C and 40C. The pelleted HNF fibroblast cells were suspended in 0.25 M sucrose/10 mM Tris maleate, pH 7.5, containing 1 mM dithiothreitol, 3 mM calcium acetate, and 2 mM magnesium acetate (pH 7.5) (buffer A) at 1D7 cells per ml and were homogenized in a stainless steel mortar with a Teflon pestle with a 229-,um clearance connected to a Tri-R homogenizer. When 80% or more of the cells were broken, as evidenced by examining the cells under phase microscopy at x430 following staining by toluidine blue, the cells were prepared for nuclei isolation in the following manner: 6.5 ml of 1.8 M sucrose in buffer A was added to 1 ml of homogenate, mixed by two up and down strokes, layered over 5 ml of 1.8 M sucrose in buffer A, and centrifuged at 40,000 x g under vacuum at 4°C for 1 hr. The nuclei pellet was resuspended in 1.0 M sucrose in buffer A by gentle homogenization and centrifuged at 10,000 x g for 10 min. The pellet at the bottom was resuspended in the desired solution and quick-frozen at -70°C.
Analysis of DNA Adducts. Nuclei prepared from cells harvested immediately after the carcinogen treatment (3 hr) as well as those refed with the CM for 8 hr after treatment were suspended in 10 mM Tris HCl/1 mM Na2EDTA buffer, pH 7.5, containing 0.1% NaDodSO4 (6-8 x 106 nuclei per ml of buffer) and quick-frozen at -700C until used for adduct analysis. Nuclear DNA was purified and analyzed by the procedure described by Tejwani et al. (15) .
Micrococcal Nuclease Digestion and Assay. The digestion and assay of the digested products were carried out by a modification of the combined procedures of Jack and Brookes (13) and Kaneko and Cerruti (21) . Briefly, the nuclei were suspended in 0.25 M sucrose/i mM Tris.HCl/0.5 mM CaCl2, pH 7.4 (digestion buffer), at co. 5 x 106 nuclei per 100 ,ul and treated with micrococcal nuclease (2.5 ,ug/ml) at 37°C; 30-/l aliquots were removed at various times between 0 and 60 min. The reaction was stopped by the addition of an equal volume of 10 mM Tris HCI/10 mM EDTA, pH 7.4, followed by addition of Sarkosyl to a final concentration of 0.5%. The nuclear lysate was then incubated with 20 ug of RNase (previously heat treated in the dark for 10 min at 100°C) per ml at 37°C for 30 min followed by treatment with 100 Ag of proteinase K per ml for 60 min at 450C. The incubation medium was mixed with an equal volume of redistilled phenol made up as a phenol reagent [phenol/chloroform/isoamyl alcohol, 24:24:1 (vol/vol)] by spinning in a vortex for 2 min. After mixing the phases, the homogeneous suspension was centrifuged at 5000 rpm for 5 min in a Beckman Microfuge, model 11. The top aqueous layer was removed and the phenol layer was extracted twice with half of the volume of 10 mM Tris HCl/10 mM EDTA, pH 7.4. The combined aqueous buffer phases were extracted once again (vol/vol), with the phenol reagent as above, and the final aqueous phase was extracted twice with water-saturated ether to remove traces of phenol. Excess ether was removed by placing the tubes in a 60C water bath for 5 min. Twentyfive microliters of calf thymus DNA at 2 mg/ml was added as a carrier and the DNA was precipitated with 2 vol of cold ethanol at -20TC overnight. The precipitate was recovered by centrifugation at 10,000 rpm (in the Microfuge) for 7 min. The precipitate was washed once carefully with cold 80% ethanol, and the pellet was dissolved in 50 ,l of 1 M HC1 by heating at 70TC for 1 hr. Following neutralization with 50 A.l of 1 M KOH (CO2 free), the solution was transferred quantitatively to a counting vial by using 150 ,4L of 50 mM Tris HCl (pH 7.5). Ten milliliters of ScintiVerse II (Fisher) was used for assaying radioactivity in a Beckman model 9000 scintillation counter. The phenol phase and the combined ethanol supernatant also were assayed for the presence of radioactivity. The 3H dpm were corrected for spillover of the 14C radiation. The Lower). Adduct analysis at the 8-hr time point was done only in one experiment. It required a large number of plates and, based on the large variation in the extent of modification in the above experiments, did not suggest that any dominant effect existed that might suggest a limiting role for DNA repair.
Since no significant difference in specific DNA modification could be detected, the distribution of the adducts on the linker versus core DNA regions was examined by the limited micrococcal nuclease digestion technique. The time course of the excision of the adducts on the nuclear DNA was followed by limited the linker DNA compared to the core DNA of the other two differently treated nuclear preparations. Chromatography of the digests by slab gel electrophoresis on 6% polyacrylamide gels did not show any detectable distinct difference in the band patterns of the DNA of the three differently treated nuclear preparations. We observed a prominent band of ca. 146 base pairs in all three nuclear preparations following a 10-to 20-min digestion.
A plot of the relative adduct concentration (3H/'4C ratio in the ethanol-precipitable material at various times of digestion divided by the 3H/14C ratio in the ethanol-precipitable material before digestion) versus the percentage of DNA digested is shown in Fig. 3 . There is a rapid decrease in the adduct concentration in the confluent cell nuclei as well as in the BZ-and B[a]P diol epoxide-treated S-phase nuclei. After the linker DNA was digested (27% digestion), the adduct concentrations became constant, indicating that Bta]P diol epoxide binds preferentially to the linker DNA. Nuclei isolated from carcinogen-only-treated S-phase cells exhibited only a slight decrease in adduct concentration during digestion.
At 27% digestion, when all of the linker DNA was solubilized, the relative adduct concentration in the core DNA of the confluent cells exposed to the B[a]P diol epoxide was 70o of the undigested DNA (Fig. 3) . This is equivalent to 2.6 times more binding to the linker DNA compared to the nucleosome core DNA (see Materials and Methods for calculation) and is in close agreement with the data of Jack and Brookes (13) for primary mouse embryo cells. S-phase cells, exposed to the carcinogen and 8IZ also, exhibited a similar binding, the relative adduct concentration in the core DNA being 68% of the total DNA and hence 2.7-fold more binding on the linker DNA. However, in the absence of BZ, this binding was considerably decreased, only 1.4 times more binding to the linker region of the nucleosomes. Since only 80% of the cells went through the S phase, the preferential binding observed in this case may be due to that fraction of the cells that did not undergo replication.
DISCUSSION
Several chemical carcinogens, including B[a]P diol epoxide, can induce neoplastic transformation of human diploid fibro-blasts (6, 15, 17) . BZ, a competitive inhibitor of chromatinassociated poly(ADP-ribose) polymerase, has been shown to inhibit transformation by a variety of chemicals, such as B[a]P diol epoxide, N-methyl-N'-nitro-N-nitrosoguanidine, and methylazoxymethanol acetate (17, 22) . The specificity of this inhibition appears to involve the covalent molecular binding of the inhibitor to the poly(ADP-ribose) polymerase-poly(ADP-ribose)-DNA complex (unpublished data).
Earlier studies (17) have shown that BZ at 1.0 mM does not have any effect on methylazoxymethanol acetate-induced strand breaks or the extent of methylation of 06-guanine, though it inhibits poly(ADP-ribose) synthesis and also the expression of neoplastic transformation by methylazoxymethanol acetate. A similar finding has been reported by Borek et al. (22) for the analogue 3-aminobenzamide. A 1.0 mM concentration of 3-aminobenzamide significantly inhibited transformation by N-methyl-N'-nitro-N-nitrosoguanidine as well as poly(ADP-ribose) synthesis, whereas it had no significant effect on repair replication, DNA synthesis by salvage pathways, and strand-breakage frequencies in x-raydamaged cells. However, contrary to our results, they found that strand-breakage frequencies in carcinogen-damaged cells increased with increasing concentration of 3-aminobenzamide. Moreover, in a more recent study, we have shown that BZ had no effect on UV-induced thymidine dimer formation or the removal of these dimers (unpublished data). However, it did inhibit transformation. The above data suggest that factors other than DNA damage and repair may be involved in the inhibition of transformation by carcinogen in the presence of BZ.
The present study was designed for detecting any possible qualitative or quantitative difference in the formation of the carcinogen-DNA adduct in the presence of BZ. The cells were treated at early S.phase of the cell cycle with the carcinogen or with BZ and carcinogen. Determination of the percentage of the radiolabeled nuclei by autoradiography, after [methyl-3H]thymidine treatment, revealed that BZ did not alter the extent of incorporation of [methyl-3H]thymidine in the nuclei involved in DNA replication during the time period of the experimental treatment. Analysis of the specific B[a]P diol epoxide-DNA adducts by HPLC, from the carcinogen-modified DNA isolated at the conclusion of the experimental treatment either with the carcinogen or with the carcinogen and BZ treatment and also at 8 hr after the treatment, did not reveal any qualitative or quantitative difference in the presence of specific carcinogen adducts formed at a transforming dose of the carcinogen.
Recent studies on the distribution of the carcinogen modifications in the DNA of the chromatin using the limited micrococcal nuclease technique have indicated preferential binding of carcinogens to the linker DNA of chromatin (14, 23) . This localized binding of the carcinogen in specific regions of DNA may play an important role in the regulation of gene expression. Jack and Brookes (13) have shown that B[a]P diol epoxide binds three times more to the linker DNA compared to the core DNA when confluent mouse embryo cells were treated. Our studies with treated confluent HNF cells also revealed similar results. There was 2.6 times more binding to the linker DNA versus core DNA. Moreover, no transformant was observed (unpublished data). HNF fibroblasts, when treated in S phase with B[a]P diol epoxide in the presence of BZ, behave similarly to the cells in G, arrest, with 2.7 times more binding to the linker DNA than to the core DNA. But preferential binding of the B[a]P diol epoxide to the linker DNA was very low (1.4 times) in the absence of BZ. It has been shown (24, 25) that nucleosomes are redistributed randomly along the nuclear DNA during replication.
The mechanism proposed to account for this redistribution during DNA synthesis is that of proteins sliding along the DNA and dissociation and reassociation of the nuclear proteins. If so, we can easily envision how preferential binding of B[a]P diol epoxide to the linker DNA of the chromatin observed in the confluent cells may be absent when the cells at S phase are treated with the carcinogen. The re-establishment of the preferential binding of the carcinogen to the Sphase chromatin in the presence of BZ, a potent poly(ADPribose) polymerase inhibitor and an anticarcinogen, suggests that poly(ADP-ribosyl)ation of the nuclear protein may be involved in an as yet unknown manner in retaining the integrity of the linker and core regions of the DNA during replication in early S phase. This, in turn, might mask the modification of certain critical sites by the carcinogen, thereby inhibiting the neoplastic transformation. Another possible explanation for the observed preferential binding of B[a]P diol epoxide to the linker DNA of B[a]P diol epoxide-and BZ-treated cells is that DNA repair occurs preferentially in the linker regions of the chromatin and this repair is inhibited by BZ. If so, the B[a]P diol epoxide-and BZ-treated cells would be expected to have higher levels of binding to linker DNA than the control S-phase cells. However, our data show that the levels of modification in the total DNA were the same in the presence and absence of BZ. If the above hypothesis is true, BZ, in addition to inhibiting repair in the linker region, would also have to cause an increased excision of adducts from the core regions to explain our results. Although BZ may have different and opposite effects on the linker and core regions, we feel it more plausible that the inhibitor may act through its effect of poly(ADP-ribose) polymerase.
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